Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

GT Healthcare and Sonder Invest $26.6 million in Potero Medical

publication date: Jul 11, 2018

GT Healthcare Capital, a China healthcare focused fund, and Sonder Capital of Silicon Valley closed a $26.6 million round in Potero Medical of San Francisco. Poterio is developing the Accuryn® Monitoring System, a urinary catheter that includes a smart sensor to monitor patients' vital signs in real-time. Intended for ICU patients, the device provides readings for intra-abdominal pressure, urine output and core body temperature. Potero says Accuryn offers early detection of Acute Kidney Injury (AKI), a serious condition that afflicts about half of all ICU patients. More details...

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming event
Shanghai , China
May 8-9, 2019
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event

Shanghai , China
March 5-6, 2019

Shanghai , China
March 26-28, 2019